Overactivation of the androgen receptor exacerbates gravid uterine ferroptosis via interaction with and suppression of the NRF2 defense signaling pathway

The mechanisms through which the androgen‐dependent activation of the androgen receptor (AR) regulates gravid uterine ferroptosis remain unknown. We show that while co‐exposure of pregnant rats to the androgen 5α‐dihydrotestosterone (DHT) and insulin (INS) triggered uterine ferroptotic signaling cascades, additional treatment with the anti‐androgen flutamide increased expression of the key ferroptosis‐inhibitory proteins SLC7A11, GSH, and GPX4; reduced iron content; normalized levels of ferroptosis‐associated Tfrc, Fpn1, and Ho1 mRNAs; reduced levels of proteins modified by 4‐HNE (a marker of ferroptosis); and restored protein levels of NRF2, a key transcription factor regulating antioxidant defense signaling, in the gravid uterus. Furthermore, exposure to DHT alone increased uterine ferroptosis, and NRF2 abundance was negatively correlated with AR status. Co‐immunoprecipitation and Western blot assays revealed that the AR physically interacted with endogenous NRF2, and this interaction was increased by DHT exposure in vivo. Our results suggest that AR overactivation and NRF2 suppression cooperate in the regulation of NRF2‐targets in uterine ferroptosis.

[1]  R. Menon,et al.  The role of nuclear factor erythroid 2–related factor 2 (NRF2) in normal and pathological pregnancy: A systematic review , 2021, American journal of reproductive immunology.

[2]  S. Palomba Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. , 2021, Human reproduction.

[3]  D. Tang,et al.  Signaling pathways and defense mechanisms of ferroptosis , 2021, The FEBS journal.

[4]  M. Brännström,et al.  Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance , 2021, Journal of Molecular Medicine.

[5]  T. Morgan,et al.  Age-related alteration in HNE elimination enzymes. , 2021, Archives of biochemistry and biophysics.

[6]  A. Gomes,et al.  Western Blotting Using In-Gel Protein Labeling as a Normalization Control: Advantages of Stain-Free Technology. , 2021, Methods in molecular biology.

[7]  M. Brännström,et al.  TLR4-associated IRF-7 and NFĸB signaling acts as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium. , 2020, The Journal of clinical endocrinology and metabolism.

[8]  L. Giudice,et al.  Endometrial function in women with polycystic ovary syndrome: a comprehensive review. , 2020, Human reproduction update.

[9]  T. Piltonen,et al.  Update on PCOS: Consequences, Challenges and Guiding Treatment. , 2020, The Journal of clinical endocrinology and metabolism.

[10]  D. Tang,et al.  Iron Metabolism in Ferroptosis , 2020, Frontiers in Cell and Developmental Biology.

[11]  H. Preissl,et al.  Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. , 2020, Reproductive biomedicine online.

[12]  D. Klionsky,et al.  Ferroptosis: machinery and regulation , 2020, Autophagy.

[13]  Ulrich Dirnagl,et al.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* , 2020, BMC Veterinary Research.

[14]  B. Wang,et al.  Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats. , 2020, The Journal of endocrinology.

[15]  D. Tang,et al.  Transcription factors in ferroptotic cell death , 2020, Cancer Gene Therapy.

[16]  J. Brosens,et al.  The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer. , 2020, Human reproduction.

[17]  Y. Keum,et al.  Binding partners of NRF2: Functions and regulatory mechanisms. , 2019, Archives of biochemistry and biophysics.

[18]  M. Bertoldo,et al.  The Mechanism of Androgen Actions in PCOS Etiology , 2019, Medical sciences.

[19]  Wei Li,et al.  Hyperandrogenism and insulin resistance‐induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome , 2019, The Journal of physiology.

[20]  P. Vandenabeele,et al.  The molecular machinery of regulated cell death , 2019, Cell Research.

[21]  J. Levine,et al.  Hyperandrogenic origins of polycystic ovary syndrome – implications for pathophysiology and therapy , 2019, Expert review of endocrinology & metabolism.

[22]  M. Olfert,et al.  Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity , 2018, International journal of environmental research and public health.

[23]  Seema Patel Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  I. Brandslund,et al.  Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort , 2018, The Journal of clinical endocrinology and metabolism.

[25]  M. Brännström,et al.  Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats. , 2018, The Journal of endocrinology.

[26]  R. Campbell,et al.  Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS. , 2018, JCI insight.

[27]  J. Jansson,et al.  Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver , 2018, Oncotarget.

[28]  D. Modi,et al.  Embryo Implantation: War in Times of Love. , 2018, Endocrinology.

[29]  D. Tuveson,et al.  Transcriptional Regulation by Nrf2 , 2017, Antioxidants & redox signaling.

[30]  D. Gibson,et al.  Androgens and endometrium: New insights and new targets , 2017, Molecular and Cellular Endocrinology.

[31]  Tobias Jung,et al.  4‐Hydroxynonenal (HNE) modified proteins in metabolic diseases , 2017, Free radical biology & medicine.

[32]  Hiroki Shima,et al.  Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2 , 2017, The Journal of Biological Chemistry.

[33]  T. Piltonen Polycystic ovary syndrome: Endometrial markers. , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[34]  C. Gargett,et al.  Fertile ground: human endometrial programming and lessons in health and disease , 2016, Nature Reviews Endocrinology.

[35]  Wei Li,et al.  Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus , 2016, Scientific Reports.

[36]  M. Fleming,et al.  The placenta: the forgotten essential organ of iron transport. , 2016, Nutrition reviews.

[37]  D. Gibson,et al.  Regulation of androgen action during establishment of pregnancy. , 2016, Journal of molecular endocrinology.

[38]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[39]  Min Hu,et al.  Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome , 2015, International journal of biological sciences.

[40]  G. Mann,et al.  Keap1-Nrf2 regulated redox signaling in utero: Priming of disease susceptibility in offspring. , 2015, Free radical biology & medicine.

[41]  Qitao Ran,et al.  Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis* , 2015, The Journal of Biological Chemistry.

[42]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[43]  H. Aburatani,et al.  Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. , 2014, Molecular endocrinology.

[44]  F. Deeba,et al.  Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. , 2014, Mymensingh medical journal : MMJ.

[45]  Akhileshwar Namani,et al.  Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer. , 2014, Biochimica et biophysica acta.

[46]  Suzanne M. McCahan,et al.  Transcriptome Analysis of the Dihydrotestosterone-Exposed Fetal Rat Gubernaculum Identifies Common Androgen and Insulin-Like 3 Targets1 , 2013, Biology of reproduction.

[47]  M. Murri,et al.  Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. , 2013, Human reproduction update.

[48]  Takahiro Matsumoto,et al.  The androgen receptor in health and disease. , 2013, Annual review of physiology.

[49]  T. Sir-Petermann,et al.  Placental steroidogenesis in pregnant women with polycystic ovary syndrome. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[50]  R. Brigelius-Flohé,et al.  Glutathione peroxidases. , 2013, Biochimica et biophysica acta.

[51]  J. Brosens,et al.  Disordered IL-33/ST2 Activation in Decidualizing Stromal Cells Prolongs Uterine Receptivity in Women with Recurrent Pregnancy Loss , 2012, PloS one.

[52]  A. Baniahmad,et al.  Androgen receptor-mediated gene repression , 2012, Molecular and Cellular Endocrinology.

[53]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[54]  B. Fauser,et al.  Pregnancy complications in women with polycystic ovary syndrome. , 2008, Seminars in reproductive medicine.

[55]  C. Ling,et al.  Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors. , 2006, The Journal of endocrinology.

[56]  Masayuki Yamamoto,et al.  Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.

[57]  M. Ferin,et al.  Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. , 2003, The Journal of clinical endocrinology and metabolism.

[58]  M. Fassnacht,et al.  Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[59]  M. Maliqueo,et al.  Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. , 2002, Human reproduction.

[60]  I. Kakizaki,et al.  Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen. , 2002, The Biochemical journal.

[61]  M. Tsai,et al.  Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. , 1999, Molecular endocrinology.

[62]  T. Li,et al.  Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. , 1998, Fertility and sterility.

[63]  C. Labrie,et al.  Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. , 1997, Urology.

[64]  M. Mattei,et al.  Structural organization and regulation of the gene for the androgen-dependent glutathione peroxidase-like protein specific to the mouse epididymis. , 1993, Molecular endocrinology.

[65]  P. Poyet,et al.  Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate , 1985, Molecular and Cellular Endocrinology.